8-氟喹啉-3-羧酸乙酯 | 71082-35-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 8-氟喹啉-3-羧酸乙酯
• 英文名称: 8-fluoro-quinoline-3-carboxylic acid ethyl ester
• 英文别名: Ethyl 8-fluoroquinoline-3-carboxylate
• CAS: 71082-35-4
• 化学式: C₁₂H₁₀FNO₂
• mdl: MFCD22581482
• 分子量: 219.215
• InChiKey: WHWANFMWJBLPCS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.166
• 拓扑面积：
  39.2
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  2-[(2,3-Difluoro-phenyl)-(toluene-4-sulfonylamino)-methyl]-acrylic acid ethyl ester 在 对甲苯磺酰胺 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 5.0h， 以75%的产率得到8-氟喹啉-3-羧酸乙酯
  参考文献：
  名称：

  Synthesis of 3-quinolinecarboxylic acid esters from the Baylis–Hillman adducts of 2-halobenzaldehyde N-tosylimines

  摘要：

  3-Quinolinecarboxylic acid ethyl esters 4 were prepared from 1. the Baylis-Hillman adducts of o-halobenzaldehyde N-tosylimines, in a one-pot reaction. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4039(01)00552-4

文献信息

• Triazole Compounds as Lipoxygenase Inhibitors
  申请人：Pelcman Benjamin

  公开号：US20090186918A1

  公开（公告）日：2009-07-23

  There is provided compounds of formula (I) wherein W is an optionally substituted aryl or heteroaryl group, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a lipoxygenase (e.g. 15-lipoxygenase) is desired and/or required, and particularly in the treatment of inflammation.

  提供了化合物的公式(I)，其中W是可选取代的芳基或杂环芳基基团，以及其药学上可接受的盐。这些化合物在治疗需要抑制脂氧合酶(例如15-脂氧合酶)活性的疾病中非常有用，特别是在治疗炎症方面。
• COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION
  申请人：Cleave Biosciences, Inc.

  公开号：US20140235548A1

  公开（公告）日：2014-08-21

  Compounds, pharmaceutical compositions, and methods of using such compounds to treat or prevent diseases or disorders associated with or mediated by JAMM proteins are disclosed. The compounds and compositions inhibit the enzymatic activity of a JAMM domain, including the JAMM domain of the CSN5 subunit of the COP9-signalsome (CSN), the JAMM domain of the Rpn11/Poh1/Psmd14 subunit of the 26S proteasome, the JAMM domain of AMSH, the JAMM domain of AMSH-LP, the JAMM domain of BRCC36, among other JAMM domains.

  本文介绍了化合物、药物组合物以及使用这些化合物治疗或预防与JAMM蛋白相关或介导的疾病或障碍的方法。这些化合物和组合物抑制JAMM域的酶活性，包括COP9信号体（CSN）的CSN5亚基的JAMM域、26S蛋白酶的Rpn11/Poh1/Psmd14亚基的JAMM域、AMSH的JAMM域、AMSH-LP的JAMM域、BRCC36的JAMM域等其他JAMM域。
• TRIAZOLE COMPOUNDS AS LIPOXYGENASE INHIBITORS
  申请人：Biolipox AB

  公开号：EP1943234A1

  公开（公告）日：2008-07-16
• [EN] TRIAZOLE COMPOUNDS AS LIPOXYGENASE INHIBITORS<br/>[FR] UTILISATION DE TRIAZOLES COMME INHIBITEURS DE LA LIPOXYGENASE
  申请人：BIOLIPOX AB

  公开号：WO2007051982A1

  公开（公告）日：2007-05-10

  [EN] There is provided compounds of formula (I) wherein W is an optionally substituted aryl or heteroaryl group, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a lipoxygenase (e.g. 15- lipoxygenase) is desired and/or required, and particularly in the treatment of inflammation.
  [FR] L'invention concerne des composés représentés par la formule (I), dans laquelle W représente un aryle ou un groupe hétéroaryle éventuellement substitué, ainsi que des sels de qualité pharmaceutique de ceux-ci. Ces composés sont utilisés dans le traitement de certaines maladies dans lesquelles l'inhibition de l'activité de la lipoxygénase (par exemple, la lipoxygénase 15) est souhaitée et/ou nécessaire, et particulièrement dans le traitement de l'inflammation.
• [EN] COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION<br/>[FR] COMPOSITION ET PROCÉDÉS POUR L'INHIBITION DES PROTÉINES JAMM
  申请人：ZHOU HAN-JIE

  公开号：WO2012158435A1

  公开（公告）日：2012-11-22

  Compounds, pharmaceutical compositions, and methods of using such compounds to treat or prevent diseases or disorders associated with or mediated by JAMM proteins are disclosed. The compounds and compositions inhibit the enzymatic activity of a JAMM domain, including the JAMM domain of the CSN5 subunit of the COP9-signalsome (CSN), the JAMM domain of the Rpn11/Poh1/Psmd14 subunit of the 26S proteasome, the JAMM domain of AMSH, the JAMM domain of AMSH-LP, the JAMM domain of BRCC36, among other JAMM domains.